Received Feb 17, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAP | DTAP (INFANRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | — | — |
| DTAPIPV | DTAP + IPV (KINRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | — | — |
| HIBV | HIB (HIBERIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | — | — |
| MNQ | MENINGOCOCCAL CONJUGATE (MENVEO) | NOVARTIS VACCINES AND DIAGNOSTICS | UNK | — | — |
| RV1 | ROTAVIRUS (ROTARIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | — | — |
RN requests stability data for Menveo (1-vial), Kinrix, Infanrix, Hiberix, Rotarix (liq) stored; This non-serious case was reported by a nurse via call center representative and described the occurrence of incorrect storage of drug in a patient who received Men ACWY-CRM NVS (Menveo) for prophylaxis. Co-suspect products included DTPa-IPV (Kinrix) for prophylaxis, DTPa (Infanrix) for prophylaxis, Hib (Hiberix) for prophylaxis and Rota (Rotarix liquid formulation) for prophylaxis. On an unknown date, the patient received Menveo, Kinrix, Infanrix, Hiberix and Rotarix liquid formulation. On an unknown date, an unknown time after receiving Menveo, Kinrix, Infanrix, Hiberix and Rotarix liquid formulation, the patient experienced incorrect storage of drug (Verbatim: RN requests stability data for Menveo (1-vial), Kinrix, Infanrix, Hiberix, Rotarix (liq) stored). The outcome of the incorrect storage of drug was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 11-FEB-2025 The register nurse requested stability data for Menveo (1-vial), Kinrix, Infanrix, Hiberix, Rotarix (liq) stored at negative 17 degree Fahrenheit for 30 days which led to incorrect storage of drug. The vaccines had been used in patients during this time as they were not frozen. The patient data was not available at time of call.